SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (17006)6/7/2005 10:46:28 PM
From: charlyt  Respond to of 52153
 
Can't say I've ever had a 50-bagger. Quite a few 10-baggers (including OSIP and SEPR mentioned above). I think I may have had some reverse 50-baggers, though, with a couple of biotechs that have ended up worthless. <g>

Peter


Me neither. My personal best was buying AMEV for $2 about a year before Lilly picked it off for $17 and change. If I was going to have a 50x, that was it. Stupid Lilly.

Certainly had my share of blowups too. All part of the fun. At the very least its more interesting than investing in utilities or retailers. Bleech.



To: Biomaven who wrote (17006)6/8/2005 4:44:39 PM
From: Sam Citron  Read Replies (2) | Respond to of 52153
 
Peter,

It's not hard to convert 20/20 hindsight into promotional material. It's only a little harder to backtest to determine what screen parameters might have identified these 10-50 baggers in their formative stages. Surprising that so few do so.

Sam